Inimmune picks up $22m Series A
Missoula, Montana-based Inimmune, a developer of immune therapies and components for more effective vaccines, has raised $22 million in Series A funding.
10 July 2020•1 min read
Missoula, Montana-based Inimmune, a developer of immune therapies and components for more effective vaccines, has raised $22 million in Series A funding.
Singapore VC plants flag in Ohio in search of US investors
26 October 2026 · 6 mins read
New AI threats are fueling VC investment in cybersecurity
22 October 2026 · 4 mins read
Inspired Capital holds quick close on $450m for Fund IV
20 October 2026 · 4 mins read
Inovia hits $200m in first close for sixth early-stage fund
19 October 2026 · 4 mins read
San Joaquin County to slow venture commitments
15 October 2026 · 2 mins read
DOWNLOAD: Fundraising holds steady in Q3
14 October 2026 · 2 mins read
Why Endeavor Catalyst is betting big on Southeast Asia
8 October 2026 · 4 mins read
